Publication Type

Journal Article

Version

submittedVersion

Publication Date

1-2008

Abstract

Where intellectual property rights (IP) owned by dominant undertakings are indispensable and impossible for other market players to replicate or acquire, the refusal to grant license to use such IP may cause serious harm to vital public interests, such as the supply of life-saving drugs, of technology that protects the environment, the compliance with de jure or de facto industry standards and the preservation of competition in markets with network effects or strong need for compatibility and interoperability

Discipline

Intellectual Property Law | Science and Technology Law

Research Areas

Innovation, Technology and the Law

Publication

International Review of Intellectual Property and Competition Law

Volume

39

Issue

7

First Page

757

Last Page

774

ISSN

0018-9855

Identifier

10.2139/ssrn.1831302

Publisher

Max-Planck-Institut für Immaterialgüter- und Wettbewerbsrecht

Additional URL

https://doi.org/10.2139/ssrn.1831302

Share

COinS